期刊文献+

NRP-1在非小细胞肺癌中的表达及临床意义 被引量:4

Expression of Nueropilin-1 in Non-small Cell Lung Cancer and Its Clinical Significance
原文传递
导出
摘要 目的探讨nueropilin-1(NRP-1)在非小细胞肺癌(NSCLC)中的表达及临床意义。方法应用免疫组化SP法检测68例NSCLC及癌旁组织中NRP-1的表达,分析其表达与NSCLC临床病理参数之间的关系。结果 NSCLC组织中NRP-1阳性表达率明显高于癌旁组织(P<0.05)。NRP-1在NSCLC组织中的表达与肿瘤直径、P-TNM分期及淋巴结转移密切相关(P<0.05)。结论 NRP-1过度表达在NSCLC发生、发展过程中起重要作用,可能与NSCLC发生侵袭和转移密切相关。 Objective To explore the expression of nueropilin-1 in non-small cell lung cancer(NSCLC) and its clinical value. Methods The expression of nueropilin-1 protein was detected with immunohistochemical SP plus non-hiotin technique in 68 cases of NSCLC and normal lung tissues.The relation between the expression of nueropilin-1 protein and the clinicopathological parameters of NSCLC was analyzed. Results The positive expression rate of nueropilin-1 protein in NSCLC was significantly higher than that in normal lung tissues(P〈0.05).The expression of nueropilin-1 protein in NSCLC was closely related to tumor diameter,P-TNM stage and lymphnode metastasis(P〈0.05). Conclusions Nueropilin-1 may play an important role in the oncogenesis and progression of NSCLC,and it may be closely correlated with invasion and metastasis of NSCLC.
作者 刘宏侠
出处 《实用预防医学》 CAS 2011年第10期1941-1943,共3页 Practical Preventive Medicine
关键词 非小细胞肺癌 nueropilin-1 免疫组织化学 Non-small cell lung cancer Nueropilin-1 Immunohistochemistry
  • 相关文献

参考文献9

二级参考文献70

共引文献17

同被引文献62

  • 1宋海平,王春友,张景辉.Neuropilin-1在胰腺癌组织及细胞系中的表达[J].肿瘤防治研究,2005,32(9):549-550. 被引量:2
  • 2Hanahan D,Weinberg RA. Hallmarks of cancer:the next genera- tion[J]. Ce11,2011,144(5) :646-674.
  • 3Soker S, Fidder H, Neufeld G, et al. Characterization of novel vascular endothelial growth factor(VEGF)receptors on tumor ceils that bind VEGF165 via its exon 7-encoded domain[J]. J Biol Chem, 1996,271 (10) :5761-5767.
  • 4Tang X, Kadara H, Behrens C, et al. Abnormalities of the TITF-1 Lineage-Specific Oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis[J]. Clin Cancer Res, 2011,17 (8) : 2434- 2443.
  • 5De Fazio S,Russo E, Ammendola M, et al. Efficacy and safety of bevacizumab in glioblastomas[J]. Curr Med Chem, 2012,19 (7) : 972-981.
  • 6Carrillo de Santa Pau E,Arias FC,Caso Peldez E,et al. Prognos- tic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in pa tients with nonsmall cell lung cancer[J]. Cancer,2009,115(8) : 1701-1712.
  • 7Donnem T, A1-Shibli K, Andersen S, et al. Combination of low vascular endothelial growth factor A (VEGF-A)/VEGF receptor 2 expression and high lymphocyte infiltration is a strong and in- dependent favorable prognostic factor in patients with nonsmall cell lung cancer[J]. Cancer,2010,116(18) 14318-4325.
  • 8Seto I-t, Hiqashiyama M, Funai H, et al. Prognostic value of ex- pression of vascular endothelial growth factor and its flt-1 and KDR receptors in stage 1 non-small-cell lung cancer[J]. Lung Cancer,2006,53(1) :91-96.
  • 9Yang F, Tang XM, Riquelme E, et al. Increased VEGFR-2 Gene Copy is associated with chemoresistance and shorter survival in patients with Non-Small-Cell lung carcinoma who receive adjuvant chemother- apy[J]. Cancer Res,2011,71(16) :5512-5521.
  • 10Brown LF, Berse B, Jackman RW, et al. Expression of vascular per- meability factor (vascular endothelial growth {actor)and its receptors in breast cancer[J]. Hum Pathol, 1995,26 (1) : 86.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部